Doctor Arthur Mader
VIVIT Institute, Feldkirch (Austria)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/5000x1496/8aa45c8224/eacvi-acronym-text-rgb.png)
The ceramide-based Coronary Event Risk Test (CERT) predicts cardiovascular mortality in cardiovascular disease patients with type 2 diabetes mellitus as well as in those without diabetes
Event: ESC Congress 2019
Topic: Biomarkers
Session: Diabetes and the heart
Serum ceramides and type 2 diabetes are mutually independent predictors of cardiovascular events in patients with peripheral artery disease
Event: ESC Congress 2019
Topic: Biomarkers
Session: Vascular disease
ESC 365 is supported by
